What technical signals does Metalabs (090370) have?

Metalabs current technical signals: no active technical signal.

Is Metalabs a cup-and-handle pattern?

No. Metalabs has no valid cup-and-handle signal right now.

What are Metalabs's financials and valuation?

Metalabs's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Metalabs

090370 · KOSPI

₩1,191-0.67%

2026-09-04 close

Metalabs last closed at ₩1,191 (-0.67%) on 2026-09-04. Listed on KOSPI; price, financials and dividends update daily after market close.

Loading chart…

No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions

303 picks

Next-day win rate

50.7%

Avg next-day

-0.11%

vs market

-0.49%p

Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.

Trade plan

EntryAccount sizeStopTarget (optional)Risk per trade (%)

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

Overall: 화장품,의류,완구 131/152 · top 86%

Factor composite · relative position in sector

PER 150.61 · PBR 0.38 — own-history percentile 92/100 · 100/100

Open self-history band

PER92/100

PBR100/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024

Distress zoneFinancial-metric reference signal

Altman Z'' zoneZ'' -0.07

Distress

Grey

Safe

The marker shows the current Z'' value within the displayed zones.

Altman Z'': -0.07
Beneish M-Score: -2.08
Sloan accrual: 3.02%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

3/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score3/9

Profitability

Positive ROAPass
Positive OCFNot passed
Improving ΔROAPass
Accruals (OCF > net income)Not passed

Leverage & liquidity

Lower debtNot passed
Higher current ratioNot passed
No new sharesNot passed

Efficiency

Higher gross marginNot passed
Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityWarning

OCF/매출 3기 연속 하락. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Margin trendWarning

영업외손익 급변 (영업이익 대비 113% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-09-05

화장품,의류,완구

This stock is in 화장품,의류,완구: revenue rank 128 of 148, share 0%.

128 / 1480%revenue share

Who dominates this industry?

1효성티앤씨8.3%
2LG생활건강7.3%
3코웨이4.6%
4영원무역홀딩스4.6%
5미스토홀딩스4.6%
6메타랩스0%

Concentration

DistributedCR3 20.3%

HHI 317148 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedDivergent lenses

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p: 1.85
Direction: 확대
Level: 좁음
Years: 8

Value lens

P90/P10: 8.3
Median P/B: 0.82
Level: 넓음
n: 135

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin: -16.3%
Interest coverage: -2.5x
Return on equity (ROE): 0.3%

Operating margin −5pp

Operating loss

Interest coverageBase -2.5x-3.3x

Return on equity (ROE)Base 0.3%-13.6%

Revenue −15%

Interest coverage risk

Interest coverageBase -2.5x-2.2x

Return on equity (ROE)Base 0.3%-9.9%

Interest rate +2pp

Interest coverage risk

Interest coverageBase -2.5x-1.8x

Return on equity (ROE)Base 0.3%-12.6%

Interest coverage limit

Already below the limit by 22.7pp

Interest coverage limit at an operating margin of 6.4%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-19

Suppliers disclosed by the company in its 2026-03-19 annual report.

Suppliers without disclosed amount

메타케어Price comovement r=0.14 (1 year)메타프라임

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

위버랩스59.59%2026-06-24 · 증감 +3.90%p
디피즈20.04%2025-10-01 · 증감 -2.48%p

Connections

AI-extracted related companies · for reference

Customers

현대백화점Price comovement r=-0.01 (1 year)

Competitors

메타랩스코웰패션LFPrice comovement r=0.15 (1 year)한섬Price comovement r=0.11 (1 year)F&FPrice comovement r=0.13 (1 year)신세계인터내셔날Price comovement r=0.09 (1 year)아모레퍼시픽Price comovement r=0.10 (1 year)LG생활건강Price comovement r=0.03 (1 year)

Same theme

삼성물산Price comovement r=-0.03 (1 year)

🔗 See in the full market map →

Recent filings

Metalabs's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

About Metalabs

What technical signals does Metalabs (090370) have?: Metalabs current technical signals: no active technical signal.
Is Metalabs a cup-and-handle pattern?: No. Metalabs has no valid cup-and-handle signal right now.
What are Metalabs's financials and valuation?: Metalabs's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy